Literature DB >> 32975437

Hyperosmolar Ionic Solutions Modulate Inflammatory Phenotype and sGAG Loss in a Cartilage Explant Model.

Ahmad S Arabiyat1,2, Hongyu Chen1,2, Josh Erndt-Marino3, Katie Burkhard1, Lisa Scola1, Allison Fleck1,2, Leo Q Wan1,2, Mariah S Hahn1,2.   

Abstract

OBJECTIVE: The objective of this study was to compare the effects of hyperosmolar sodium (Na+), lithium (Li+) and potassium (K+) on catabolic and inflammatory osteoarthritis (OA) markers and sulfated glycosaminoglycan (sGAG) loss in TNF-α-stimulated cartilage explants.
METHODS: Explants from bovine stifle joints were stimulated with TNF-α for 1 day to induce cartilage degradation followed by supplementation with 50 mM potassium chloride (KCl), 50 mM lithium chloride (LiCl), 50 mM sodium chloride (NaCl), or 100 nM dexamethasone for an additional 6 days. We assessed the effect of TNF-α stimulation and hyperosmolar ionic treatment on sGAG loss and expression of OA-associated proteins: ADAMTS-5, COX-2, MMP-1, MMP-13, and VEGF.
RESULTS: TNF-α treatment increased sGAG loss (P < 0.001) and expression of COX-2 (P = 0.018), MMP-13 (P < 0.001), and VEGF (P = 0.017) relative to unstimulated controls. Relative to activated controls, LiCl and dexamethasone treatment attenuated sGAG loss (P = 0.008 and P = 0.042, respectively) and expression of MMP-13 (P = 0.005 and P = 0.036, respectively). In contrast, KCl treatment exacerbated sGAG loss (P = 0.032) and MMP-1 protein expression (P = 0.010). NaCl treatment, however, did not alter sGAG loss or expression of OA-related proteins. Comparing LiCl and KCl treatment shows a potent reduction (P < 0.05) in catabolic and inflammatory mediators following LiCl treatment.
CONCLUSION: These results suggest that these ionic species elicit varying responses in TNF-α-stimulated explants. Cumulatively, these findings support additional studies of hyperosmolar ionic solutions for potential development of novel intraarticular injections targeting OA.

Entities:  

Keywords:  cartilage explant; hyperosmolar solution; inflammation; lithium; osteoarthritis; potassium; sodium

Mesh:

Substances:

Year:  2020        PMID: 32975437      PMCID: PMC8804856          DOI: 10.1177/1947603520961167

Source DB:  PubMed          Journal:  Cartilage        ISSN: 1947-6035            Impact factor:   3.117


  65 in total

Review 1.  The role of the chondrocyte in osteoarthritis.

Authors:  M B Goldring
Journal:  Arthritis Rheum       Date:  2000-09

2.  High salt reduces the activation of IL-4- and IL-13-stimulated macrophages.

Authors:  Katrina J Binger; Matthias Gebhardt; Matthias Heinig; Carola Rintisch; Agnes Schroeder; Wolfgang Neuhofer; Karl Hilgers; Arndt Manzel; Christian Schwartz; Markus Kleinewietfeld; Jakob Voelkl; Valentin Schatz; Ralf A Linker; Florian Lang; David Voehringer; Mark D Wright; Norbert Hubner; Ralf Dechend; Jonathan Jantsch; Jens Titze; Dominik N Müller
Journal:  J Clin Invest       Date:  2015-10-20       Impact factor: 14.808

3.  Lithium protects cartilage from cytokine-mediated degradation by reducing collagen-degrading MMP production via inhibition of the P38 mitogen-activated protein kinase pathway.

Authors:  Wang Hui; Gary J Litherland; Matthew Jefferson; Matt J Barter; Martina S Elias; Tim E Cawston; Andrew D Rowan; David A Young
Journal:  Rheumatology (Oxford)       Date:  2010-07-15       Impact factor: 7.580

4.  Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.

Authors:  Medora M Hardy; Karen Seibert; Pamela T Manning; Mark G Currie; B Mark Woerner; Dorothy Edwards; Alane Koki; Catherine S Tripp
Journal:  Arthritis Rheum       Date:  2002-07

Review 5.  Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review.

Authors:  B J E de Lange-Brokaar; A Ioan-Facsinay; G J V M van Osch; A-M Zuurmond; J Schoones; R E M Toes; T W J Huizinga; M Kloppenburg
Journal:  Osteoarthritis Cartilage       Date:  2012-09-07       Impact factor: 6.576

Review 6.  Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis.

Authors:  Egemen Ayhan; Hayrettin Kesmezacar; Isik Akgun
Journal:  World J Orthop       Date:  2014-07-18

7.  Chondrocyte death in mechanically injured articular cartilage--the influence of extracellular calcium.

Authors:  Anish K Amin; James S Huntley; Peter G Bush; A Hamish R W Simpson; Andrew C Hall
Journal:  J Orthop Res       Date:  2009-06       Impact factor: 3.494

Review 8.  In vitro models for the study of osteoarthritis.

Authors:  Craig I Johnson; David J Argyle; Dylan N Clements
Journal:  Vet J       Date:  2015-07-14       Impact factor: 2.688

Review 9.  Current research on pharmacologic and regenerative therapies for osteoarthritis.

Authors:  Wei Zhang; Hongwei Ouyang; Crispin R Dass; Jiake Xu
Journal:  Bone Res       Date:  2016-03-01       Impact factor: 13.567

10.  A Membrane Potential- and Calpain-Dependent Reversal of Caspase-1 Inhibition Regulates Canonical NLRP3 Inflammasome.

Authors:  Yifei Zhang; Hua Rong; Fang-Xiong Zhang; Kun Wu; Libing Mu; Junchen Meng; Bailong Xiao; Gerald W Zamponi; Yan Shi
Journal:  Cell Rep       Date:  2018-08-28       Impact factor: 9.423

View more
  2 in total

1.  Small extracellular vesicles in combination with sleep-related circRNA3503: A targeted therapeutic agent with injectable thermosensitive hydrogel to prevent osteoarthritis.

Authors:  Shi-Cong Tao; Ji-Yan Huang; Yuan Gao; Zi-Xiang Li; Zhan-Ying Wei; Helen Dawes; Shang-Chun Guo
Journal:  Bioact Mater       Date:  2021-05-06

2.  Dual protective role of velutin against articular cartilage degeneration and subchondral bone loss via the p38 signaling pathway in murine osteoarthritis.

Authors:  Kelei Wang; Xuanyuan Lu; Xinyu Li; Yufeng Zhang; Rongjian Xu; Yun Lou; Yanben Wang; Tan Zhang; Yu Qian
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.